News Image

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical; Initial Acquisition for Planned International Network of Interventional Psychiatry Clinics

Provided By PR Newswire

Last update: Mar 31, 2025

MIAMI, March 31, 2025 /PRNewswire/ -- HOPE Therapeutics, Inc., ("HOPE," the "Company"), an interventional psychiatry network wholly owned by NRx Pharmaceuticals, Inc. ("NRx") (Nasdaq: NRXP), today announced signing of a definitive Agreement to acquire Dura Medical (Dura), per the previously announced non-binding Letter of Intent.  Dura, together with the previously announced Neurospa network, are anticipated to provide a comprehensive service offering to patients on Florida's west coast. Dura is revenue generating and EBITDA positive.

Read more at prnewswire.com

NRX PHARMACEUTICALS INC

NASDAQ:NRXP (7/18/2025, 8:00:02 PM)

After market: 3 +0.06 (+2.04%)

2.94

-0.09 (-2.97%)



Find more stocks in the Stock Screener

Follow ChartMill for more